Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatropin with leuprorelin versus somatropin alone versus no treatment in pubertal children with idiopathic short stature
2005-001750-25Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2006
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial of somatropin and leuprolide in Idiopathic Short Stature (ISS) (3 arms), sponsored by Eli Lilly and Company. Started Oct 2006; status: completed.
02
Drugs
somatropinleuprolide
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on 2005-001750-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001750-25.